ILAE-Africa
News
About ILAE
Epilepsy: A Public Health Priority
This WHA Side event will bring together policy makers, NGOs, patients, health care leaders and Member States to develop next steps for implementing Resolution WHA68.20. Ministries of Health from different WHO regions will identify the underlying systemic issues that affect access to universal health care (UHC) and essential medicines for persons with epilepsy in their regions. The newly crafted Global Epilepsy report will be presented, and key directions for an Epilepsy Action Plan will be identified. The speakers will address the barriers to epilepsy care, make recommendations to strengthen systems and practices, and issue a call for urgent action by all key stakeholders nationally and internationally.
14 May, 2019
About ILAE
In memoriam: Colin David Binnie (1938-2019)
It is with great sadness that we announce the death of Prof. Colin David Binnie, clinical neurophysiologist, on 21st March 2019. Colin had a long and distinguished career in clinical neurophysiology. Colin played a major role in a number of early phase drug studies, notably the early studies of Lamotrigine and developed the model of photosensitivity as a method for acute single dose efficacy studies of potential AEDs. Also he was active as initiator or participant in a number of international projects in the fields of computer assisted spike detection and digital EEG.
9 May, 2019
Clinical Research
Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis
Epilepsy after resolved encephalitis was rare in our cohort of patients with AIE treated with immunotherapy. In addition, seizure freedom is achieved faster and more frequently after immunotherapy. Therefore, AEDs should be considered as add-on treatment, and similar to treatment of other encephalitis symptoms, immunotherapy is crucial.
6 May, 2019
Clinical Research
Refractory juvenile myoclonic epilepsy: a meta‐analysis of prevalence and risk factors
We aimed to determine the prevalence and prognostic risk factors for refractoriness of JME. One‐third of people with JME were refractory, which is a higher prevalence than expected. Risk factors were identified and can be used to guide treatment and counselling of people with JME.
1 May, 2019
About ILAE
ILAE-Africa Newsletter
Read the latest ILAE-Africa bulletin to find out about recent achievements and events as well as goals for the 2017-2021 term in Ghana, Nigeria, Uganda, Malia, and the Ivory Coast, as well as upcoming activities and events for 2019.
15 April, 2019
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community